- Report
- September 2025
- 193 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 142 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 184 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 182 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 192 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 184 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 193 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 278 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 377 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 186 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 285 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 385 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 280 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 376 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 196 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 381 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 278 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 280 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 238 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 266 Pages
Global
From €5171EUR$5,850USD£4,474GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more